http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018058791-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87e50445b84fe4d8bbe8189988184a6f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 |
| filingDate | 2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c05e85d8f70b4fa6488abd711595d6ff |
| publicationDate | 2018-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2018058791-A |
| titleOfInvention | PCSK9 inhibitor and food composition for improving cholesterol metabolism |
| abstract | A novel PCSK9 inhibitor is provided. A compound represented by formula (1) or a salt thereof. [R 1 to R 6 are each independently C5, 10 or 15 prenyl group, C1-15 alkylcarbonyl group, C2-15 alkenylcarbonyl group, hydroxyl group substituted / unsubstituted C1-15 alkyl group, hydroxyl group And the double line between the dotted line and the solid line independently represents a single line independently of each other, and is a substituted / unsubstituted C2-15 alkenyl group or one or more of H, R 1 to R 6 is a C5, 10 or 15 prenyl group; Bond or double bond] [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018058792-A |
| priorityDate | 2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.